Clinical trial

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

NCT06803784

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention Genetic: whole genome sequencing Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention whole exome sequencing Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-02-04

PhaseN/A

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Amyotrophic Lateral Sclerosis (ALS)unresolved

Frontotemporal Dementia (FTD)unresolved

Alzheimer&#39;s Disease (AD)unresolved

Interventions

Genetic: whole genome sequencingGENETIC

whole exome sequencingGENETIC

Sponsors & collaborators

Neuromed IRCCSlead sponsor

Università del Piemonte Orientale AOU Maggiore della Carità - Novaracollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06803784 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.